A new study assessed how well clinicians adhere to National Institute for Health and Care Excellence’s (NICE) delirium ...

A report published Wednesday in The BMJ questioned the safety and effectiveness of the Alzheimer’s disease drug Kisunla ...

US Senator Kevin Cramer (R-ND) criticized the new federal minimum staffing rule for nursing homes during a speech on the ...

Tavapadon, a drug made by AbbVie to treat Parkinson’s disease, met phase 3 TEMPO-1 trial goals treated early Parkinson's disease and improved motor skills, the company reported on Thursday.

Ownership groups and lenders may be equally bullish about the senior care market in the year ahead, but that doesn’t mean borrowers should expect a stampede of lending offers for all their needs.

COVID deaths in nursing home jumped 43% this summer versus summer 2023 amid low vaccine coverage, a new report from AARP finds.

A new study defined the ethnic differences of amyloid beta and cognitive trajectories in Koreans and non-Hispanic whites (NHWs).

Virtual programs delivered during the pandemic were effective and useful for people living with dementia and their informal caregivers, a new study finds.

Long-term care providers in California who participate in the state’s Medicare program must now post on their websites their ...

A new report sheds light on how a Parkinson’s disease drug may impair decision-making and lead to harmful behaviors like ...

Long-term care providers and others have felt the sting of False Claims Act litigation more than they ever cared to through ...

Providers can't be so tied to tech investments that they miss the opportunity to innovate or improve workload for staff, ...